Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Alltranz
AddedFeb 15, 2024
UpdatedJun 18, 2026
Alltranz

Alltranz

Alltranz Inc.: A pharmaceutical company founded in 2004, specializing in dermal delivery R&D.

HQ
Lexington, KY, US
Founded
2004
Overview
Compare
Fundraising
Employees
Website

Alltranz Inc. is a pharmaceutical company founded in 2004, specializing in the research and development of dermal delivery products. The company's core mission is to innovate and enhance the delivery of pharmaceutical compounds through the skin, aiming to improve patient outcomes and convenience. Their market focus includes both commercial physical and biological research sectors, targeting applications that benefit from advanced dermal delivery systems.

Notable affiliated individuals and investors include experts in pharmaceutical sciences and dermatology, though specific names are not provided. Key achievements of Alltranz include the development of proprietary technologies and formulations that have set new standards in dermal drug delivery. The overall impact of Alltranz has been significant in advancing the field of transdermal therapeutics, contributing to more effective and user-friendly medication administration methods.

Alltranz - Similar Companies

Transport Pharmaceuticals logo

Transport Pharmaceuticals

Trana Discovery logo

Trana Discovery

Alltrna logo

Alltrna

alltrna.com

Outplay logo

Outplay

outplayinc.com

Transpire Bio logo

Transpire Bio

transpirebio.com

Transcera logo

Transcera

Avro Life Science logo

Avro Life Science

Concours Pharmaceuticals logo

Concours Pharmaceuticals

Allander Biotechnologies logo

Allander Biotechnologies

Ziran Biopharmaceutical logo

Ziran Biopharmaceutical

CarthroniX logo

CarthroniX

carthronix.com

Skinvisible logo

Skinvisible

skinvisible.com

Alavita Pharmaceuticals logo

Alavita Pharmaceuticals

alavita.lu

Vascarta logo

Vascarta

vascarta.com

Iontera logo

Iontera

Alltranz - Quick Facts

Who are Alltranz's competitors?

Companies similar to Alltranz include Transport Pharmaceuticals, Trana Discovery, Alltrna and Outplay.

When was Alltranz founded?

Alltranz was founded in 2004.

Where is Alltranz's headquarters located?

Alltranz's headquarters is located in Lexington, KY, US.

When was Alltranz's last funding round?

Alltranz's most recent funding round was for $860k (USD) in July 2007.

How much has Alltranz raised to-date?

As of Jul 16, 2007, Alltranz has raised a total of $860k (USD).

How many employees does Alltranz have?

Alltranz has 4 employees as of Feb 4, 2024.

Alltranz - Classification

Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • Australianew Zealand
Revenue
  • Licensing
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Delivery
  • Pharmaceuticals
NAICS
  • 620000Health Care and Social Assistance
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified